Heather A Lankes Selected Research

Heather A Lankes Research Topics

Disease

24	Neoplasms (Cancer) 10/2022 - 01/2011
10	Endometrial Neoplasms (Endometrial Cancer) 10/2022 - 11/2012
9	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 01/2011
8	Carcinoma (Carcinomatosis) 01/2023 - 03/2012
5	Disease Progression 02/2020 - 12/2012
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2020 - 01/2020
4	Ovarian Epithelial Carcinoma 01/2020 - 03/2012
3	Endometrioid Carcinoma 01/2023 - 01/2016
2	Adenocarcinoma 01/2021 - 12/2017
2	Carcinosarcoma 12/2017 - 01/2017
1	Endometriosis 01/2023
1	Neoplasm Metastasis (Metastasis) 11/2020
1	Dermatitis 01/2020
1	Kidney Neoplasms (Kidney Cancer) 01/2020
1	Hypertension (High Blood Pressure) 02/2018
1	Hypoxia (Hypoxemia) 02/2018
1	Uterine Diseases (Endometrial Disease) 01/2018
1	Leiomyosarcoma 01/2017
1	Fallopian Tube Neoplasms 01/2017
1	Uterine Cervical Dysplasia 01/2017
1	Microsatellite Instability 01/2016
1	Sarcoma (Soft Tissue Sarcoma) 10/2012
1	Carcinogenesis 10/2012
1	Peritoneal Neoplasms 01/2011

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2023 - 05/2011
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2011
5	Bevacizumab (Avastin)FDA Link 10/2022 - 01/2018
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2020 - 10/2014
4	Carboplatin (JM8)FDA LinkGeneric 01/2020 - 01/2017
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 01/2018
3	Tyrosine Kinase InhibitorsIBA 01/2023 - 11/2012
3	IpilimumabIBA 11/2020 - 01/2020
3	PlatinumIBA 01/2020 - 01/2017
3	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 10/2012
2	Dasatinib (BMS 354825)FDA Link 01/2023 - 10/2012
2	temsirolimus FDA Link 10/2022 - 01/2018
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 11/2020 - 01/2020
2	Interleukin-8 (Interleukin 8)IBA 11/2020 - 02/2018
2	copanlisibIBA 08/2020 - 02/2020
2	NivolumabIBA 01/2020 - 01/2020
2	ixabepilone (BMS 247550)FDA Link 01/2018 - 01/2017
2	1-dodecylpyridoxal (PLD)IBA 11/2017 - 01/2017
2	ErbB Receptors (EGF Receptor)IBA 11/2012 - 05/2011
2	Lapatinib (GW572016)FDA Link 11/2012 - 03/2012
1	RNA (Ribonucleic Acid)IBA 08/2022
1	Insulin-Like Growth Factor Binding ProteinsIBA 01/2021
1	Insulin-Like PeptidesIBA 01/2021
1	entinostat (MS 275)IBA 01/2021
1	Medroxyprogesterone Acetate (Depo-Provera)FDA LinkGeneric 01/2021
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Histone Deacetylase InhibitorsIBA 01/2021
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Estrogens (Estrogen)FDA Link 01/2021
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2021
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2021
1	CytokinesIBA 11/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Lipase (Acid Lipase)FDA Link 01/2020
1	Combined VaccinesIBA 12/2019
1	pazopanib FDA Link 02/2018
1	MicroRNAs (MicroRNA)IBA 12/2017
1	CholesterolIBA 11/2017
1	poly(ethylene glycol)-co-poly(ethyleneimine)IBA 11/2017
1	liposomal doxorubicin (Doxil)FDA Link 11/2017
1	Interleukin-12 (IL 12)IBA 11/2017
1	VTX-2337IBA 01/2017
1	Proteasome InhibitorsIBA 01/2017
1	Bortezomib (Velcade)FDA Link 01/2017
1	Celecoxib (Celebrex)FDA Link 01/2017
1	MLN 8237IBA 01/2017
1	TubulinIBA 01/2017
1	SynucleinsIBA 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	WD repeat containing planar cell polarity effectorIBA 01/2016
1	Secreted Frizzled-Related ProteinsIBA 01/2016
1	cediranib (AZD2171)IBA 09/2015
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 10/2014
1	brivanibIBA 10/2014
1	AZD 6244IBA 02/2013
1	afliberceptIBA 12/2012
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 11/2012
1	src-Family KinasesIBA 10/2012
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 06/2012
1	Peptides (Polypeptides)IBA 06/2012
1	acetyl- lysyl- prolyl- seryl- seryl- prolyl- prolyl- glutamyl- glutamic acid amideIBA 06/2012
1	RacivirIBA 06/2012
1	Epidermal Growth Factor (EGF)IBA 03/2012
1	Cisplatin (Platino)FDA LinkGeneric 05/2011
1	Cetuximab (Erbitux)FDA Link 05/2011
1	Sorafenib (BAY 43-9006)FDA Link 01/2011

Therapy/Procedure

11	Therapeutics 10/2021 - 09/2015
8	Drug Therapy (Chemotherapy) 10/2022 - 03/2012
3	Immunotherapy 11/2020 - 01/2017
1	Chemoradiotherapy 01/2020
1	Drug Tapering 01/2017
1	Activities of Daily Living (ADL) 01/2017
1	Hysterectomy 09/2015